What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing by CVS Health is to officially announce and provide access to its financial results for the fourth quarter and the full fiscal year ended December 31, 2022, through a press release that is incorporated by reference.

Where can I find the actual financial results and performance numbers?

The detailed financial results, including revenue, earnings per share, and other key performance indicators, are located in the press release dated February 8, 2023, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for specific figures.

Does this filing contain any new strategic information or business updates?

This particular 8-K filing is focused solely on the announcement of financial results. It does not appear to contain information on new strategic initiatives, mergers, acquisitions, or other material business updates. Those would typically be disclosed under different 8-K item numbers if they occurred.

What does it mean that the information is 'furnished' and not 'filed'?

When information is 'furnished' under Item 2.02 of an 8-K (like earnings releases), it means the SEC has access to it, but it is not subject to the same liability provisions as information that is formally 'filed' under Section 18 of the Exchange Act. This is a standard practice for earnings announcements and does not typically indicate a lack of importance for investors.

CVS 8-K: Earnings & Results

Summary

CVS Health Corporation (CVS) filed an 8-K on February 8, 2023, to announce its financial results for the fourth quarter and full year ended December 31, 2022. The report itself does not contain the detailed financial figures but rather incorporates by reference a press release (Exhibit 99.1) issued on the same date. This filing is crucial for investors as it provides the latest official performance metrics from the company. While the 8-K doesn't detail the numbers, investors should refer to the furnished press release for key financial data, including revenue, earnings per share, and any forward-looking guidance provided by CVS Health. This information is essential for assessing the company's operational performance, profitability, and future outlook.

Key Highlights

1CVS Health filed an 8-K on February 8, 2023, reporting financial results for Q4 and full year 2022.
2The 8-K incorporates by reference a press release (Exhibit 99.1) dated February 8, 2023, containing the detailed financial results.
3Investors need to consult the referenced press release for specific financial figures and performance details.
4The filing is primarily a procedural announcement of financial results, rather than a disclosure of new material events.
5Information provided is furnished and not deemed 'filed' for specific regulatory purposes under the Exchange Act, a common practice for earnings releases.
6The filing indicates the company is adhering to its reporting schedule for financial performance.

CVS HEALTH Corp 8-K Report, Financial Results (Feb 8, 2023)

Summary

Key Highlights

Frequently Asked Questions